Hints and tips:
...(The court ruling did not name that transaction but it was the similarly troubled 2017 Abbott/ Alere merger, according to a person familiar with the matter.)...
...He led the turnround of medical diagnostics maker Alere before overseeing its sale to Abbott in 2017 for $7.8bn including debt....
...The new deal values Alere’s equity at $5.3bn, down from $5.8bn when the all-cash takeover was first announced in February 2016....
...The FTSE 100 company said on Wednesday that Olivier Bohuon would step down next month after seven years as chief executive and would be replaced by Mr Nawana, who headed the medical diagnostics company Alere...
...Alere’s value....
...In January, Abbott announced it would buy Alere for $6bn in cash, a hefty 50 per cent premium....
...Abbott will also assume Alere’s net debt of $2.6bn. Miles D....
...Shares in Alere , a provider of diagnostic tests, surged almost 45.5 per cent to $54.11 after industry heavyweight Abbott Laboratories agreed to acquire it for $56 a share....
...Alere will become a subsidiary of Abbott in a deal that is expected to result in annual pre-tax synergies of $500m by 2019....
...Analysts with the investment bank said Alere would have difficulty surpassing year ago comparisons. Shares in Alere fell 1 per cent to $35.71 while Stericycle slipped 1 per cent to $117.82....
...“Alere believes that Axis-Shield’s share price is trading at current levels primarily as a result of the offer and not due to underlying fundamentals,” said Alere....
...and market conditions, that it could pursue to achieve its strategic objectives,” said Alere....
...Alere owns 29.9 per cent of Axis-Shield’s shares and has extended the offer deadline by a fortnight to October 24....
...A person close to Axis-Shield said it was not surprised by Alere’s actions....
...Monday is the final opportunity for Axis-Shield to release new information to persuade shareholders to hold out for US-based Alere to sweeten its offer, and follows an extension on Friday of Alere’s deadline...
...- Axis-Shield recommends improved offer of 470p a share from Alere — statement. - F&C Asset Management says CEO to retire; Edward Bramson appointed executive chairman – statement....
...Analysts say Alere is unlikely to succeed with a bid of less than 550p a share. Alere says this valuation rests on swift approval of the panel....
...Its shares firmed 1.8 per cent to 458p after US rival Alere went hostile with its 460p a share offer....
...Alere went hostile with a 460p a share offer last week....
...“This is a shot across the bows – it’s not [Alere’s] final offer,” he said....
...“We think Axis’ business is of considerable strategic value to Alere and our analysis suggests that a price of between 530p and 570p would be closer to fair value.”...
...Takeover target Axis-Shield was in focus after US medical group peer Alere, which went hostile with a 460p-a-share cash offer on Friday, revealed an increased holding of 6.4 per cent....
...Axis-Shield improved 4 per cent to 468p after the board of the medical diagnostics group reluctantly recommended a revised 470p a share offer by its US suitor Alere....
...The interest shown by Alere may prompt attention from alternative bidders, the broker added....
...Philip Green could open a BHS store in Bradford as part of revived plans for a Westfield shopping centre in the city From The Scottish Herald, - Construction woes add to finance fears - Alere...
International Edition